|
|
||||||||
Department of Medicine, McGill University Health Center, McGill University, Montreal, Quebec, Canada
In the rat passive Heymann nephritis model of membranous
nephropathy, complement C5b-9 induces sublethal glomerular epithelial
cell (GEC) injury and proteinuria. C5b-9 activates cytosolic
phospholipase A2 (cPLA2), and products of
cPLA2-mediated phospholipid hydrolysis modulate GEC injury
and proteinuria. In the present study, we demonstrate that C5b-9
activates c-Jun N-terminal kinase (JNK) in cultured rat GECs and that
JNK activity is increased in glomeruli isolated from proteinuric rats
with passive Heymann nephritis, as compared with control rats. Stable
overexpression of cPLA2 in GECs amplified
complement-induced release of arachidonic acid (AA) and JNK activity,
as compared with neo (control) GECs. Activation of JNK was not affected
by indomethacin. Incubation of GECs with complement stimulated
production of superoxide, and pretreatment with the antioxidants,
N-acetylcysteine, glutathione, and
-tocopherol as
well as with diphenylene iodonium, an inhibitor of the NADPH oxidase,
inhibited complement-induced JNK activation. Conversely,
H2O2 activated JNK, whereas exogenously added
AA stimulated both superoxide production and JNK activity.
Overexpression of a dominant-inhibitory JNK mutant or treatment with
diphenylene iodonium exacerbated complement-dependent GEC injury. Thus,
activation of cPLA2 and release of AA facilitate
complement-induced JNK activation. AA may activate the NADPH oxidase,
leading to production of reactive oxygen species, which in turn mediate
the activation of JNK. The functional role of JNK activation is to
limit or protect GECs from complement attack.
This article has been cited by other articles:
![]() |
F. Y. Ma, R. S. Flanc, G. H. Tesch, Y. Han, R. C. Atkins, B. L. Bennett, G. C. Friedman, J.-H. Fan, and D. J. Nikolic-Paterson A Pathogenic Role for c-Jun Amino-Terminal Kinase Signaling in Renal Fibrosis and Tubular Cell Apoptosis J. Am. Soc. Nephrol., February 1, 2007; 18(2): 472 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Cybulsky, R. J. Quigg, and D. J. Salant Experimental membranous nephropathy redux Am J Physiol Renal Physiol, October 1, 2005; 289(4): F660 - F671. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Cybulsky, T. Takano, J. Papillon, K. Bijian, and J. Guillemette Activation of the extracellular signal-regulated kinase by complement C5b-9 Am J Physiol Renal Physiol, September 1, 2005; 289(3): F593 - F603. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nangaku, S. J. Shankland, and W. G. Couser Cellular Response to Injury in Membranous Nephropathy J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1195 - 1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Cybulsky, T. Takano, J. Papillon, A. Khadir, K. Bijian, and L. Le Berre The actin cytoskeleton facilitates complement-mediated activation of cytosolic phospholipase A2 Am J Physiol Renal Physiol, March 1, 2004; 286(3): F466 - F476. [Abstract] [Full Text] |
||||
![]() |
L. Aoudjit, M. Stanciu, H. Li, S. Lemay, and T. Takano p38 Mitogen-activated protein kinase protects glomerular epithelial cells from complement-mediated cell injury Am J Physiol Renal Physiol, October 1, 2003; 285(4): F765 - F774. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |